In atopic dermatitis models, ligustilide up-regulates filaggrin and SPTLC1, and reduces tumor necrosis factor-α (TNF-α), interferon-γ, and interleukin-6 (IL-6) to reinforce skin barrier function [10]. Here, IL6 is linked to atopic eczema.